Moderna’s newly approved mRNA flu injection, mFLUSIVA (mRNA-1010), already accumulated 78 reports in the Vaccine Adverse Event Reporting System (VAERS) through the October 30, 2026 data release.
Among them are accounts of sudden inability to walk, partial vision loss, cardiac arrhythmias, fainting, and hospitalization. [Read More]